1 193

Cited 57 times in

Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases

Authors
 Jae Y. Ro  ;  Steven S. Shen  ;  Hyang I. Lee  ;  Eun K. Hong  ;  Yoon H. Lee  ;  Nam H. Cho  ;  Soo J. Jung  ;  Yeong J. Choi  ;  Alberto G. Ayala 
Citation
 AMERICAN JOURNAL OF SURGICAL PATHOLOGY, Vol.32(5) : 752-757, 2008 
Journal Title
 AMERICAN JOURNAL OF SURGICAL PATHOLOGY 
ISSN
 0147-5185 
Issue Date
2008
MeSH
Aged ; Aged, 80 and over ; Biomarkers, Tumor/analysis ; Carcinoma in Situ/pathology ; Carcinoma, Transitional Cell/chemistry ; Carcinoma, Transitional Cell/pathology* ; Carcinoma, Transitional Cell/therapy ; Cell Nucleus/pathology ; Combined Modality Therapy ; Cystoscopy ; Cytoplasm/pathology ; Humans ; Immunohistochemistry ; Male ; Middle Aged ; Neoplasm Staging ; Plasma Cells/pathology* ; Prognosis ; Treatment Outcome ; Urinary Bladder Neoplasms/chemistry ; Urinary Bladder Neoplasms/pathology* ; Urinary Bladder Neoplasms/therapy
Keywords
plasmacytoid ; transitional cell carcinoma ; urothelial neoplasm ; variant
Abstract
In this report, we summarized the clinicopathologic features of 9 cases of plasmacytoid transitional cell carcinoma (TCC) of the urinary bladder, a rare variant of TCC. All 9 patients were men with a mean of age 64.3 years (range, 46 to 81 y). All but 1 patient presented with gross hematuria; the remaining patient had urgency and microscopic hematuria. Cystoscopic findings revealed a dominant solid mass with surrounding multiple papillary lesions in 6 cases and multiple masslike lesions in 3 other cases. The initial diagnosis of plasmacytoid TCC was made on transurethral resection in 8 cases and cystoscopic biopsy in 1. One patient had TNM stage I disease, 2 had stage II disease, 3 had stage III disease, and 3 had stage IV disease. Four patients were treated by radical cystectomy with chemotherapy, 2 by radical cystectomy alone, 1 each by chemotherapy or intravesical bacillus Calmette-Guerin infusion alone, and 1 did not receive any further therapy. Microscopically, all tumors contained plasmacytoid cells, which composed 30% to 100% of the entire tumor. Eight of 9 cases were associated with high-grade TCC, and transitional cell carcinoma in situ was present in 4 cases. The plasmacytoid tumor cells were characterized by eccentrically located nuclei and abundant eosinophilic cytoplasm. Interestingly, plasmacytoid transitional cell carcinoma in situ was noted in 1 case. Immunohistochemical staining demonstrated that both plasmacytoid and conventional TCC components were positive for cytokeratins 7 and 20. The mean Ki-67 labeling index was 30% (range, 10% to 50%), and p53 expression in the majority of cases was low (5% to 10%), except for in 2 cases (70% and 80%). The mean follow-up in 8 patients was 24.5 months (range, 5 to 47 mo); the other patient was lost to follow-up. Five patients died of disease from 5 to 36 months, 2 patients were alive with disease at 30 and 47 months, and 1 patient was alive and well at 36 months with no evidence of disease. In summary, plasmacytoid TCC tends to present at an advanced stage and to have a poor prognosis. Morphologic recognition and distinction from other plasmacytoid malignant neoplasms is critical for its clinical management and immunohistochemical studies may be required for differential diagnosis.
Full Text
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00000478-200805000-00012&LSLINK=80&D=ovft
DOI
10.1097/PAS.0b013e318159af9e
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
Yonsei Authors
Cho, Nam Hoon(조남훈) ORCID logo https://orcid.org/0000-0002-0045-6441
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/107238
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse